TWI800489B - Ｆｇｆｒ４抑制劑及其製備方法和應用 - Google Patents

Ｆｇｆｒ４抑制劑及其製備方法和應用 Download PDF

Info

Publication number
TWI800489B
TWI800489B TW106127294A TW106127294A TWI800489B TW I800489 B TWI800489 B TW I800489B TW 106127294 A TW106127294 A TW 106127294A TW 106127294 A TW106127294 A TW 106127294A TW I800489 B TWI800489 B TW I800489B
Authority
TW
Taiwan
Prior art keywords
applications
preparation methods
fgfr4 inhibitors
fgfr4
inhibitors
Prior art date
Application number
TW106127294A
Other languages
English (en)
Other versions
TW201805286A (zh
Inventor
高鵬
孫廣俊
譚松良
劉磊
包如迪
Original Assignee
大陸商江蘇豪森藥業集團有限公司
大陸商上海翰森生物醫藥科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大陸商江蘇豪森藥業集團有限公司, 大陸商上海翰森生物醫藥科技有限公司 filed Critical 大陸商江蘇豪森藥業集團有限公司
Publication of TW201805286A publication Critical patent/TW201805286A/zh
Application granted granted Critical
Publication of TWI800489B publication Critical patent/TWI800489B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
TW106127294A 2016-08-12 2017-08-11 Ｆｇｆｒ４抑制劑及其製備方法和應用 TWI800489B (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CN201610668101.5 2016-08-12
??201610668101.5 2016-08-12
CN201610668101 2016-08-12
CN201611187674.2 2016-12-20
CN201611187674 2016-12-20
??201611187674.2 2016-12-20

Publications (2)

Publication Number Publication Date
TW201805286A TW201805286A (zh) 2018-02-16
TWI800489B true TWI800489B (zh) 2023-05-01

Family

ID=61162773

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106127294A TWI800489B (zh) 2016-08-12 2017-08-11 Ｆｇｆｒ４抑制劑及其製備方法和應用

Country Status (6)

Country Link
US (1) US11608332B2 (zh)
EP (1) EP3498707A4 (zh)
JP (1) JP7088906B2 (zh)
CN (1) CN109563091B (zh)
TW (1) TWI800489B (zh)
WO (1) WO2018028664A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110240598B (zh) * 2018-03-09 2023-07-25 上海翰森生物医药科技有限公司 甲酰胺衍生物的制备方法及其中间体化合物
CN108558869B (zh) * 2018-05-10 2019-04-09 西安培华学院 用于治疗肝癌的化合物及其制剂
TWI723480B (zh) 2018-07-27 2021-04-01 大陸商北京加科思新藥研發有限公司 用作fgfr4抑制劑的稠環衍生物
CN111138459B (zh) * 2018-11-06 2022-10-18 南京圣和药业股份有限公司 Fgfr4抑制剂的光学异构体及其应用
CN111662285B (zh) * 2019-03-07 2023-05-16 江苏豪森药业集团有限公司 2-氧代-1,3-氧杂氮杂环庚衍生物的制备方法
JP2022537415A (ja) * 2019-06-21 2022-08-25 ターンズ・ファーマシューティカルズ・インコーポレイテッド Ｆｇｆｒ４を阻害するための化合物
CN113072550B (zh) * 2020-01-06 2023-08-08 周龙兴 一种高选择性成纤维细胞生长因子受体抑制剂和应用
WO2022089648A1 (en) * 2020-11-02 2022-05-05 Jacobio Pharmaceuticals Co., Ltd. Crystalline forms of salts of fgfr4 inhibitor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010119284A1 (en) * 2009-04-15 2010-10-21 Astex Therapeutics Limited Bicyclic heterocyclyl derivatives as fgfr kinase inhibitors for therapeutic use
CN104011051A (zh) * 2011-10-28 2014-08-27 阿斯特克斯治疗有限公司 通过fgfr激酶抑制抗癌的吡啶并吡嗪
CN105683188A (zh) * 2013-10-25 2016-06-15 诺华股份有限公司 作为fgfr4抑制剂的稠环二环吡啶基衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170114254A (ko) * 2016-03-24 2017-10-13 재단법인 대구경북첨단의료산업진흥재단 신규한 피리딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 fgfr 관련 질환의 예방 또는 치료용 약학적 조성물
JP7103952B2 (ja) 2016-05-20 2022-07-20 江▲蘇▼豪森▲薬▼▲業▼集▲団▼有限公司 Ｆｇｆｒ４阻害剤、その製造方法及び応用
US11352353B2 (en) * 2016-05-27 2022-06-07 Hangzhou Innogate Pharma Co., Ltd. Heterocyclic compound serving as FGFR4 inhibitor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010119284A1 (en) * 2009-04-15 2010-10-21 Astex Therapeutics Limited Bicyclic heterocyclyl derivatives as fgfr kinase inhibitors for therapeutic use
CN104011051A (zh) * 2011-10-28 2014-08-27 阿斯特克斯治疗有限公司 通过fgfr激酶抑制抗癌的吡啶并吡嗪
CN105683188A (zh) * 2013-10-25 2016-06-15 诺华股份有限公司 作为fgfr4抑制剂的稠环二环吡啶基衍生物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
網路文獻 Wenjun Zhou et al., "A Structure-Guided Approach to Creating Covalent FGFR Inhibitors", Chemistry & Biology 17, 285–295, March 26, 2010. *

Also Published As

Publication number Publication date
WO2018028664A1 (zh) 2018-02-15
US20220024913A1 (en) 2022-01-27
EP3498707A1 (en) 2019-06-19
US11608332B2 (en) 2023-03-21
JP7088906B2 (ja) 2022-06-21
EP3498707A4 (en) 2020-04-08
TW201805286A (zh) 2018-02-16
JP2019527701A (ja) 2019-10-03
CN109563091B (zh) 2022-04-29
CN109563091A (zh) 2019-04-02

Similar Documents

Publication Publication Date Title
EP3444250A4 (en) FGFR4 INHIBITOR, PROCESS FOR PREPARATION AND CORRESPONDING APPLICATIONS
EP3524603A4 (en) FGFR4 INHIBITOR, PRODUCTION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
AU2015330506B2 (en) EGFR inhibitor, and preparation and application thereof
EP3463386A4 (en) OLIGONUCLEOTIDES, COMPOSITIONS AND METHOD THEREFOR
EP3355637A4 (en) Information sending, information determining and relationship determining methods and devices
EP3090239A4 (en) Spectrometry systems, methods, and applications
EP3270694A4 (en) Certain chemical entities, compositions, and methods
EP3224815A4 (en) Geolocation bracelet, systems, and methods
EP3497087A4 (en) CERTAIN CHEMICALS, COMPOSITIONS AND METHODS
EP3186277A4 (en) Antibodies, compositions, and uses
EP3157466A4 (en) Prostheticcapsular devices, systems, and methods
EP3107479A4 (en) Mechanical joints, and related systems and methods
EP3169376A4 (en) Multiple memory materials and systems, methods and applications therefor
EP3104865A4 (en) Micro-organoids, and methods of making and using the same
EP3268362A4 (en) Substituted pyridines and uses thereof
EP3334706A4 (en) PILLARARENES AND USES THEREOF
TWI800489B (zh) Ｆｇｆｒ４抑制劑及其製備方法和應用
EP3283516A4 (en) ANTI-PACAP ANTIBODIES AND USES THEREOF
EP3110895A4 (en) Polysilocarb materials, methods and uses
EP3369734A4 (en) KINASEINHIBITOR AND METHOD OF PREPARATION AND PHARMACEUTICAL USE THEREOF
EP3347021A4 (en) CYANO-THIENOTRIAZOLOAZEPINES AND THEIR USES
EP3346021A4 (en) HARD COATING AND COVERED HARD COVERED ELEMENT
EP3552017A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
EP3346022A4 (en) HARD COATING AND ELEMENT COVERED WITH HARD COATING
EP3467043A4 (en) HEAT-CONDUCTING ELEMENT, HEAT-CONDUCTING COMPOSITION AND PRODUCTION METHOD FOR HEAT-CONDUCTING COMPOSITION